Clinical Trial Update: Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of TQC2731 injection in severe asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TQC2731

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Severe Asthma | Phase 2 | Status: COMPLETED